PDCD1 and hepatocellular carcinoma: The ameliorated anticancer activity and tumor immune microenvironment induced by the combination of R848@M2pep-MPsAFP and anti-PD-1 antibody were further confirmed in diethylnitrosamine (DEN)-induced autochthonous HCC models (Fig. 7a).